Richard A. Graham - 19 Nov 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, DEVELOPMENT
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
19 Nov 2021
Net transactions value
-$35,639
Form type
4
Filing time
23 Nov 2021, 19:23:27 UTC
Previous filing
24 Aug 2021
Next filing
06 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $35,639 -4,263 $8.36 $169,061 19 Nov 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
F2 Includes 119 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2021.